Across Africa, a quiet revolution is unfolding in fertility clinics and IVF centers, offering hope to millions struggling to conceive. But this rapid growth brings urgent questions—who safeguards patients? Who ensures treatments are both safe and accessible?

Key facts

  • Assisted reproductive technology (ART) is experiencing significant expansion across the continent
  • Current growth is primarily driven by private investment
  • Experts argue this boom requires robust public governance frameworks
  • Without regulation, risks include ethical violations and unequal access

The Private Surge

Private money is flooding into Africa's fertility sector, building state-of-the-art clinics in urban centers from Nairobi to Lagos. Investors see potential in a market serving populations where infertility rates remain high due to various medical and environmental factors.

Yet this commercial expansion creates a two-tier system—those who can afford cutting-edge treatments, and those left behind. The absence of strong public oversight means quality standards vary wildly, and ethical boundaries sometimes blur.

The Governance Gap

What's missing, analysts stress, isn't investment but intelligent regulation. Public governance could establish safety protocols, standardize success rate reporting, and prevent exploitative practices that sometimes target vulnerable patients desperate for solutions.

Without national frameworks, patients navigate a fragmented landscape where clinic quality might depend more on marketing budgets than medical outcomes.

A Call for Balance

The solution isn't to stifle private innovation but to complement it with public stewardship. Governments could develop accreditation systems, monitor outcomes, and ensure some services remain accessible to lower-income families through public health partnerships.

This isn't about restricting growth but guiding it—making sure Africa's fertility boom helps build families without compromising ethics or equity.